Investment objectives and strategy
This fund aims to achieve an increase in value whilst suppressing volatility and risk, through a conservative allocation of assets between, primarily, international equities, fixed interest securities and cash or money market instruments. Exposure to equities is limited to a maximum of 50% and exposure to fixed income securities is limited to a maximum of 70%. Exposure to currencies, other than base currency, after hedging, will not exceed 50%. The fund is created as a “sleep at night” investment to look beyond the market cycles and volatile shifts.
This fund is suitable for an investor looking to achieve long-term growth of capital, accepting a low to moderate degree of risk.
Why the Ashburton Asset Management Fund?
- The fund aims to achieve an increase in value while it suppresses volatility and risk
- It’s a conservative allocation of assets between, primarily, international equities, fixed interest securities and cash or money market instruments
- Designed to give investors peace of mind while generating inflation-beating growth with low to moderate risk
The Multi Asset Team
||Low to moderate
Cumulative performance since 1992:
*Hover on chart to see values
Notice | EGM conclusion
As you may
be aware, the Board of Replica distributed notices to the shareholders of (i)
Sterling Asset Management Fund, (ii) Dollar Asset Management Fund and (iii)
Euro Asset Management Fund (Asset Management Funds) whereby the Board
proposed that the Asset Management Funds be converted to feeder funds to invest
into the Global Balanced Fund of the Ashburton Investments SICAV, an
established UCITS fund that is domiciled in Luxembourg.
of this notice, we hereby confirm that the Extraordinary General Meetings of
the Asset Management Funds were held on 6 November 2023 whereby the
shareholders approved proposals set forth during the meetings.
result, all dealings of subscriptions and redemptions in the Asset Management
Funds will be suspended from 14 November 2023 to 16 November 2023 with dealings
to recommence on 17 November 2023.
To view the shareholder notices and other related documentation, click here.